YCBD EBITDA | cbdMD, Inc.

cbdMD, Inc. (YCBD) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$1.13M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$800.78K; Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA (m); Operating income -$286.29K; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$904.69K; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2016-09-30 to 2021-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$1.13M	(m)	(m)	(m)	$18.07K*	-$442.16K*	(m)	(m)	(m)	(m)
2026-03-31	Reported	(m)	-$800.78K	(m)	(m)	(m)	$5.75K*	-$722.50K*	(m)	(m)	(m)	(m)
2025-12-31	Reported	(m)	-$286.29K	(m)	(m)	(m)	$164.80K	-$812.46K	(m)	(m)	(m)	(m)
2025-06-30	Reported	(m)	-$904.69K	(m)	(m)	(m)	$1.48K*	-$704.20K*	(m)	(m)	(m)	(m)
2025-03-31	Reported	(m)	-$485.82K	(m)	(m)	(m)	$15.51K*	-$189.48K*	(m)	(m)	(m)	(m)
2024-12-31	Reported	(m)	-$86.27K	(m)	(m)	(m)	$164.39K	-$317.95K	(m)	(m)	(m)	(m)
2024-06-30	Reported	(m)	-$382.03K	(m)	(m)	(m)	$0.00*	$289.78K*	(m)	(m)	(m)	(m)
2024-03-31	Reported	(m)	-$1.55M	(m)	(m)	(m)	-$4.62K*	-$704.07K*	(m)	(m)	(m)	(m)
2023-12-31	Reported	(m)	-$1.07M	(m)	(m)	(m)	$184.63K	-$105.88K	(m)	(m)	(m)	$0.00
2023-06-30	Reported	(m)	-$1.82M	(m)	(m)	(m)	$102.39K*	-$240.57K*	(m)	(m)	(m)	$0.00
2023-03-31	Reported	(m)	-$1.40M	(m)	(m)	(m)	-$102.39K*	-$1.73M*	(m)	(m)	(m)	$0.00
2022-12-31	Reported	(m)	-$4.05M	(m)	(m)	(m)	$177.37K	-$2.06M	(m)	(m)	(m)	$0.00
2022-06-30	Reported	-$32.96M*	-$33.13M	$169.59K*	(m)	(m)	$88.43K*	-$2.37M*	(m)	(m)	(m)	$0.00
2022-03-31	Reported	-$4.75M*	-$5.01M	$260.05K*	(m)	(m)	$142.76K*	-$5.20M*	(m)	(m)	(m)	$0.00
2021-12-31	Reported	-$24.8M	(m)	(m)	(m)	-251.65%	$231.03K	-$5.47M	(m)	(m)	(m)	$0.00
2021-09-30	Reported	-$6.72M	(m)	(m)	(m)	-64.63%	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Reported	-$6.43M*	-$6.68M	$246.53K*	(m)	(m)	(m)	-$4.61M*	(m)	(m)	(m)	$103.00K
2021-03-31	Reported	-$3.93M*	-$4.17M	$240.67K*	(m)	(m)	(m)	-$2.96M*	(m)	(m)	(m)	-$536.00K
2020-12-31	Reported	-$1.53M	(m)	(m)	(m)	-12.39%	(m)	-$2.19M	(m)	(m)	(m)	$332.00K
2020-09-30	Reported	-$4.31M	(m)	(m)	(m)	-36.84%	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Reported	-$1.13M*	-$1.34M	$211.94K*	(m)	(m)	(m)	-$1.13M*	(m)	(m)	(m)	$0.00
2020-03-31	Reported	-$5.43M*	-$5.60M	$174.21K*	(m)	(m)	(m)	-$4.27M*	(m)	(m)	(m)	$0.00
2019-12-31	Reported	-$6M	(m)	(m)	(m)	-59.12%	(m)	-$4.87M	(m)	(m)	(m)	-$2.24M
2019-09-30	Reported	-$5.19M	(m)	(m)	(m)	-54.42%	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Reported	-$6.37M*	-$6.47M	$100.77K*	(m)	(m)	(m)	-$4.59M*	(m)	(m)	(m)	-$1.09M
2019-03-31	Reported	-$1.92M*	-$2.03M	$106.94K*	(m)	(m)	(m)	-$3.30M*	(m)	(m)	(m)	-$1.07M
2018-12-31	Reported	-$1.03M	(m)	(m)	(m)	-220.58%	(m)	-$1.16M	(m)	(m)	(m)	-$133.00K
2018-09-30	Reported	-$2.69M	(m)	(m)	(m)	41.39%	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Reported	$680.10K*	$627.25K	$52.85K*	(m)	(m)	(m)	-$1.29M*	(m)	(m)	(m)	$62.00K
2018-03-31	Reported	$1.68M*	$1.62M	$55.87K*	(m)	(m)	(m)	-$1.73M*	(m)	(m)	(m)	-$23.00K
2017-12-31	Reported	-$1.24M	(m)	(m)	(m)	-285.48%	(m)	-$1.82M	(m)	(m)	(m)	-$33.00K
2017-09-30	Reported	-$246,685.00	(m)	(m)	(m)	37.85%	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Reported	-$164.03K*	-$178.55K	$14.52K*	(m)	(m)	(m)	-$133.68K*	(m)	(m)	(m)	-$36.64K
2017-03-31	Reported	-$192.87K*	-$211.31K	$18.44K*	(m)	(m)	(m)	-$755.03K*	(m)	(m)	(m)	$76.89K
2016-12-31	Reported	-$686,306.00	(m)	(m)	(m)	-343.43%	(m)	-$528.64K	(m)	(m)	(m)	$2.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-09-30	Reported	(m)	-$2.16M	(m)	(m)	(m)	$184.17K	-$1.45M	(m)	(m)	(m)	$0.00
2024-09-30	Reported	(m)	-$3.32M	(m)	(m)	(m)	$190.01K	-$352.79K	(m)	(m)	(m)	$0.00
2023-09-30	Reported	(m)	-$22.49M	(m)	(m)	(m)	$297.55K	-$4.30M	(m)	(m)	(m)	$0.00
2022-09-30	Reported	(m)	-$78.27M	(m)	(m)	(m)	$688.68K	-$14.97M	(m)	(m)	(m)	$0.00
2021-09-30	Reported	-$18.6M	(m)	(m)	(m)	-39.29%	$342.01K	-$14.09M	(m)	(m)	(m)	-$895.00K
2020-09-30	Reported	-$16.86M	(m)	(m)	(m)	-40.26%	(m)	-$10.66M	(m)	(m)	(m)	$1.35M
2019-09-30	Reported	-$14.51M	(m)	(m)	(m)	-61.34%	(m)	-$15.38M	(m)	(m)	(m)	-$2.36M
2018-09-30	Reported	-$1.57M	(m)	(m)	(m)	-342.97%	(m)	-$5.57M	(m)	(m)	(m)	$0.00
2017-09-30	Reported	-$1.29M	(m)	(m)	(m)	-47.01%	(m)	-$2.33M	(m)	(m)	(m)	$25.00K
2016-09-30	Reported	-$3.84M	(m)	(m)	(m)	-189.18%	(m)	-$2.90M	(m)	(m)	(m)	$8.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BONK, INC. (BNKK)	United States	$0.011B	-0.14
Caring Brands, Inc. (CABR)	United States	$0.013B
UNITED GUARDIAN INC (UG)	United States	$0.034B	13.30
Axil Brands, Inc. (AXIL)	United States	$0.042B	17.24
SOLESENCE, INC. (SLSN)	United States	$0.058B	-25.13
EDGEWELL PERSONAL CARE Co (EPC)	United States	$1.261B	-13.27
COTY INC. (COTY)	United States	$2.307B	-3.15
INTERPARFUMS INC (IPAR)	United States	$3.707B	21.36
e.l.f. Beauty, Inc. (ELF)	United States	$5.934B
Kenvue Inc. (KVUE)	United States	$33.844B	22.14